MIG Capital

inbolt is featured in the cover story of Venture Capital Journal! 🌟 🦾 Their AI software is transforming robots with #3D vision, allowing them to work more like humans in complex environments. “We bring vision to the robot, so we bring in eyes and the brain,” says Inbolt's co-founder and CEO Rudy Cohen. TUM Venture Labs Albane Dersy Oliver Kahl SOSV #VCJ #Robotics #AI #VentureCapital

So proud of Albane Dersy, co-founder and COO at inbolt, for her work and impact. 🚀 🎙️ Check out this insightful discussion on the latest podcast episode with Universal Robots. Albane brilliantly explains how #AI, #vision, and #robotics are revolutionizing automation in unstructured production environments. 🦾

📣 NEW INVESTMENT 📣 We're so excited to announce that MIG Capital co-leads a €63 million Series A round in SciRhom to accelerate iRhom2-targeting therapies in a wide range of autoimmune diseases! 👩🏽⚕️ 𝐖𝐡𝐲 𝐰𝐞 𝐛𝐞𝐥𝐢𝐞𝐯𝐞 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐢𝐧𝐯𝐞𝐬𝐭𝐦𝐞𝐧𝐭:   🧪 𝐓𝐨𝐩-𝐧𝐨𝐭𝐜𝐡 𝐬𝐜𝐢𝐞𝐧𝐜𝐞 SciRhom aims to revolutionize autoimmune disease treatment by targeting iRhom2, a key regulator in disease-related signaling pathways. 🩵 𝐇𝐢𝐠𝐡 𝐩𝐨𝐭𝐞𝐧𝐭𝐢𝐚𝐥 𝐢𝐦𝐩𝐚𝐜𝐭 iRhom2's transformative potential offers hope for patients with currently difficult-to-treat autoimmune diseases. 👩🏽🤝👨🏼 𝐄𝐱𝐩𝐞𝐫𝐭 𝐭𝐞𝐚𝐦 SciRhom is led by an ambitious and dedicated team with extensive experience in pharma, biotech R&D, and clinical development. 💸 𝐒𝐭𝐫𝐨𝐧𝐠 𝐢𝐧𝐯𝐞𝐬𝐭𝐨𝐫 𝐛𝐚𝐜𝐤𝐢𝐧𝐠 The oversubscribed round, co-led by MIG Capital and an international syndicate including Andera Partners, Kurma Partners, Hadean Ventures, and Wellington Partners, joint by other new and existing investors including Bayern Kapital, HTGF | High-Tech Gründerfond, and PhiFund Ventures, demonstrates strong confidence in SciRhom's vision.   Dr. Fei Tian, Principal at MIG Capital, comments: “SciRhom's impressive team and innovative approach align with our goal to support disruptive companies with high value and impact. Joining international life science investors in this oversubscribed round bolsters support for SciRhom's novel iRhom2-targeting antibodies as they move into clinical development.” Our entire team is looking forward to the time ahead with SciRhom! 👏🏼 Jens Ruhe Jan Poth Matthias Schneider MIG Fonds Matthias Kromayer

🔍 Insights from Matthias Kromayer at BayOConnect in Munich! 🔍 This week, Matthias Kromayer held a presentation at BayOConnect by BioM Biotech Cluster Development GmbH. Under the theme "Reflections on AI from an Agnostic VC Investor," Matthias shared MIG Capital’s reflections on the potential impact of #AI within the #biopharma value chain. Key points included: 🚀 The Fight: Understanding the role of AI in revolutionizing clinical trials. 📊 Analysis: Breaking down AI’s potential in enhancing trial design, site selection, real-time monitoring, and patient experiences. 🔍 Conclusion: Assessing AI’s transformative power across the biopharma value chain, from early development to market approval. #BayOConnect2024 was fun – see you next year! 💡 Bayerisches Staatsministerium für Wirtschaft, Landesentwicklung und Energie | Roche Deutschland

🚀 Excited to share that Innatera has secured $21M in Series A funding!   "Innatera's SNP tech is set to revolutionize energy-efficient computing. We're happy to be part of their journey and look forward to the impact they’ll make", says Dr. Soren Hein, Partner at MIG Capital. Proud to support Innatera's groundbreaking Spiking Neural Processor (SNP) technology – way to go! ⭐️

📣 NEW INVESTMENT 📣 We're excited to announce that MIG Capital has invested in GlassPoint, Inc to boost solar thermal power for decarbonized industrial heat at scale! 𝐀 𝐟𝐞𝐰 𝐫𝐞𝐚𝐬𝐨𝐧𝐬 𝐰𝐡𝐲 𝐰𝐞 𝐭𝐡𝐢𝐧𝐤 𝐭𝐡𝐢𝐬 𝐢𝐬 𝐚 𝐠𝐫𝐞𝐚𝐭 𝐢𝐧𝐯𝐞𝐬𝐭𝐦𝐞𝐧𝐭: 🏭 There’s literally a burning platform: Industrial represents 26% of global energy consumption and more than 10% of global CO2 emission is generated for industrial heat by firing fossil fuels ☀ With multiple projects in California and the Middle East, GlassPoint’s solar thermal tech is currently the only proven solution to decarbonize process heat at (Gigawatt) scale at the lowest possible cost 🤝 Founder and CEO Rod MacGregor and his team in the US, Germany, the UK and Middle East have built a strong pipeline of projects, incl. joint plans with Ma'aden to develop the world’s largest industrial solar thermal project that will save 600,000 tons of CO2 per year 💸 We’re happy to join prominent smart money investors including cleantech infrastructure investor 300ppm, former Australian MP Malcolm Turnbull, former Alcoa COO Tómas Sigurðsson and veteran tech investor Bart Markus Dr. Soren Hein, Partner at MIG Capital, explains: “𝘋𝘦𝘴𝘱𝘪𝘵𝘦 𝘰𝘮𝘯𝘪𝘱𝘳𝘦𝘴𝘦𝘯𝘵 𝘯𝘦𝘵-𝘻𝘦𝘳𝘰 𝘨𝘰𝘢𝘭𝘴, 𝘱𝘳𝘰𝘤𝘦𝘴𝘴 𝘩𝘦𝘢𝘵 𝘪𝘴 𝘢 𝘴𝘦𝘤𝘵𝘰𝘳 𝘵𝘩𝘢𝘵 𝘪𝘴 𝘤𝘳𝘶𝘤𝘪𝘢𝘭 𝘺𝘦𝘵 𝘶𝘯𝘥𝘦𝘳𝘢𝘥𝘥𝘳𝘦𝘴𝘴𝘦𝘥 𝘪𝘯 𝘵𝘦𝘳𝘮𝘴 𝘰𝘧 𝘥𝘦𝘤𝘢𝘳𝘣𝘰𝘯𝘪𝘻𝘢𝘵𝘪𝘰𝘯. 𝘉𝘺 𝘩𝘢𝘳𝘯𝘦𝘴𝘴𝘪𝘯𝘨 𝘵𝘩𝘦 𝘱𝘰𝘸𝘦𝘳 𝘰𝘧 𝘵𝘩𝘦 𝘴𝘶𝘯 𝘪𝘯 𝘢 𝘶𝘯𝘪𝘲𝘶𝘦 𝘸𝘢𝘺, 𝘎𝘭𝘢𝘴𝘴𝘗𝘰𝘪𝘯𝘵 𝘴𝘵𝘢𝘯𝘥𝘴 𝘰𝘶𝘵 𝘪𝘯 𝘢 𝘴𝘦𝘢 𝘰𝘧 𝘪𝘯𝘯𝘰𝘷𝘢𝘵𝘰𝘳𝘴 𝘢𝘴 𝘵𝘩𝘦 𝘰𝘯𝘭𝘺 𝘱𝘳𝘰𝘷𝘦𝘯 𝘴𝘰𝘭𝘶𝘵𝘪𝘰𝘯 𝘵𝘰 𝘵𝘳𝘢𝘯𝘴𝘧𝘰𝘳𝘮 𝘵𝘩𝘪𝘴 𝘜𝘚𝘋 444𝘣𝘯 𝘮𝘢𝘳𝘬𝘦𝘵. 𝘛𝘩𝘪𝘴 𝘪𝘯𝘷𝘦𝘴𝘵𝘮𝘦𝘯𝘵 𝘪𝘴 𝘢 𝘵𝘦𝘴𝘵𝘢𝘮𝘦𝘯𝘵 𝘵𝘰 𝘔𝘐𝘎 𝘊𝘢𝘱𝘪𝘵𝘢𝘭’𝘴 𝘥𝘦𝘥𝘪𝘤𝘢𝘵𝘪𝘰𝘯 𝘵𝘰 𝘌𝘚𝘎 𝘢𝘯𝘥 𝘪𝘮𝘱𝘢𝘤𝘵 𝘱𝘳𝘪𝘯𝘤𝘪𝘱𝘭𝘦𝘴.” This is our second new portfolio company in 2024 after our investment in HawkCell in March. More to follow very soon. Stay tuned! 🚀 Frederick Michna, Christina Vogt-Sasse, Robert Worthington, Jacob Drejer, Markus Balz, Dave Tickner, Howar Talabany, Henri de Bokay #VentureCapital #investment #ESG #deeptech MIG Fonds

🚀 3 takeaways for successful people & culture management in #startups from our portfolio day 🚀 Here are the key #takeaways from our insightful panels, speakers, and discussions: 1️⃣ 𝐑𝐞𝐬𝐢𝐥𝐢𝐞𝐧𝐜𝐞 𝐌𝐚𝐭𝐭𝐞𝐫𝐬 Building mental resilience is crucial. We learned that preparing for challenges involves training flexibility, reacting adaptively to stressful situations, and fostering harmony, vision, and creativity. 2️⃣ 𝐄𝐟𝐟𝐞𝐜𝐭𝐢𝐯𝐞 𝐏𝐞𝐫𝐟𝐨𝐫𝐦𝐚𝐧𝐜𝐞 𝐌𝐚𝐧𝐚𝐠𝐞𝐦𝐞𝐧𝐭 Measuring employee performance and providing feedback is essential. Whether through direct performance reviews or periodic assessments, transparency with employees is key. 3️⃣ 𝐂-𝐋𝐞𝐯𝐞𝐥 𝐒𝐲𝐧𝐞𝐫𝐠𝐲 At the executive level, it's imperative that personalities and types align well. Identifying character types and pairing them effectively can help create a strong company culture. Big thank you to Abby Napp for moderating and Lene Reuter (Vosberg) for your insightful speech on emotional resilience! We had an incredible time last week gathering with our amazing #portfolio companies to discuss key topics impacting our businesses today. Excited to implement these learnings. 🤜🏼🤛🏼

🚀 How can #3D and #AI solutions make robots even smarter? Albane Dersy, cofounder of inbolt, shows us how it's done! She recently showcased their groundbreaking product, GuideNOW, a real-time robot guidance solution 🦾 GuideNOW is set to transform industrial automation with its system which includes a 3D camera, Inbrain for real-time workpiece localization, and GuideNOW Studio for training AI on CAD models or 3D scans. Amazing work inbolt! 🙌 #portfolionews

📣 Discover the best fundraising strategies for healthcare and life science founders! In this latest #podcast episode of Healthcare Minutes, Dr. Fei Tian chats with Leonard Rinser about navigating #VC funding in a challenging market. Gain behind-the-scenes insights from a doctor-turned-VC on healthcare and life science investments. 👉🏼 Listen to the full episode here: - Spotify: https://lnkd.in/eu-6HauV - Apple Podcasts: https://lnkd.in/eVE48Wvv - Website: https://lnkd.in/eFqWw-WY 💬 Key #topics discussed: ▶ Business Models   ▶ Market Validation   ▶ Investment Patterns   ▶ Network Importance in Healthcare   ▶ Investor Traction   ▶ Valuation Approach   ▶ Finding the Right VC   ▶ VC Red-Flags   ▶ Market Dynamics  What an insightful talk! 👏🏼